A Commitment to Immunology

Investigators at the Carter Immunology Center seek a fundamental understanding of how the immune system works in order to develop the revolutionary new treatments focused on controlling the immune response for major diseases such as cancer, heart disease and asthma.

Immunological research is intensely multi-disciplinary and ideally collaborative, relying on well-trained immunologists interacting with researchers in other biomedical disciplines. These considerations drive our organization and educational programs. We identify, train, and support the career paths of the next generation of immunology researchers.
COVID-19 Discovery by Jie Sun, PhD and Colleagues Points to New Treatment to Protect High-Risk Patients
COVID-19 Discovery by Jie Sun, PhD and Colleagues Points to New Treatment to Protect High-Risk Patients

The new research from UVA’s Jie Sun, PhD, and colleagues suggests a way to protect patients with obesity or diabetes from the runaway inflammation and dangerous blood sugar spikes that COVID-19 can cause. Such patients are at high risk for … Read More

Dr. Melanie Rutkowski awarded new grant, Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
Dr. Melanie Rutkowski awarded new grant, Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis

Title: Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis Amount: 2.2M (~440K/year).  Dates: 3/1/23 – 2/27/28 Congratulations Dr. Rutkowski!

Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.  
Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.  

Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.   They recently met in NYC with the … Read More

Sanja Arandjelovic, PhD Awarded Two Grants for $2.5 Million to Study Molecular Mechanisms and Targeted Therapies for Rheumatoid Arthritis
Sanja Arandjelovic, PhD Awarded Two Grants for $2.5 Million to Study Molecular Mechanisms and Targeted Therapies for Rheumatoid Arthritis

Sanja Arandjelovic, PhD, an assistant professor in the Department of Nephrology, received two NIH awards for $2.5 million to study molecular mechanisms and targeted therapies for rheumatoid arthritis. The first project “Understanding a Molecular Cascade that Drives Neutrophil Mediated Pathology … Read More